{
    "match": true,
    "technologies": [
        {
            "name": "Biotechnology (focused on molecules and cells)",
            "priority": 1,
            "evidence": "Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality, 'AVC-Boosters', designed to safely deliver targeted and potent monotherapy, with broad applicability in oncology."
        },
        {
            "name": "Artificial Intelligence (AI) and Data",
            "priority": 2,
            "evidence": "The platform was designed combining decades of antibody engineering know-how, in silico design capabilities and immunology expertise."
        }
    ],
    "reason_no_match": null
}